| Expression pattern: |
UP |
| Associated gene: |
PFN2, Ago2 |
| Associated microRNA: |
miR-383-5p |
| Biological function: |
circ-ADAM9 promotes proliferation, migration, invasion, tumor growth and radioresistance, while inhibiting apoptosis in breast cancer cells; circ-ADAM9 knockdown impairs malignant phenotypes and enhances radiosensitivity. |
| Molecular mechanism: |
circ-ADAM9 acts as a competing endogenous RNA by sponging miR-383-5p, thereby increasing PFN2 expression and promoting breast cancer progression and radioresistance. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); radioresistance (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Clinical Sample Validation; Transfection; Colony Formation Assay; MTT; Annexin V/PI Flow Cytometry; Western Blot; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
circ-ADAM9 is up-regulated in breast cancer tissues and cells. It promotes malignant phenotypes and radioresistance by sponging miR-383-5p and increasing PFN2 expression; knockdown of circ-ADAM9 suppresses proliferation, migration, invasion and tumor growth while enhancing apoptosis and radiosensitivity. |
| Confidence score: |
0.8119 |